» Authors » P J Pazzaglia

P J Pazzaglia

Explore the profile of P J Pazzaglia including associated specialties, affiliations and a list of published articles. Areas
Snapshot
Articles 22
Citations 334
Followers 0
Related Specialties
Top 10 Co-Authors
Published In
Affiliations
Soon will be listed here.
Recent Articles
1.
Kollins S, Rush C, Pazzaglia P, Ali J
Exp Clin Psychopharmacol . 1998 Dec; 6(4):367-74. PMID: 9861551
The rate of onset of a drug's effect is an important determinant of its abuse potential. This experiment examined the acute behavioral effects of orally administered sustained-release methylphenidate (SR; 20-40...
2.
Pazzaglia P, Post R, Ketter T, Callahan A, Marangell L, Frye M, et al.
J Clin Psychopharmacol . 1998 Oct; 18(5):404-13. PMID: 9790159
Of 30 patients with treatment-refractory affective illness, 10 showed a moderate to marked response to blind nimodipine monotherapy compared with placebo on the Clinical Global Impressions Scale. Fourteen inadequately responsive...
3.
Rush C, Pazzaglia P
Alcohol Clin Exp Res . 1998 May; 22(2):539-47. PMID: 9581666
The acute subject-rated, performance-impairing, and physiological effects of ethanol (0, 0.5, and 1 g/kg) were examined after pretreatment with isradipine (0, 5, and 10 mg) in nine healthy volunteers. Volunteers...
4.
Rush C, Armstrong D, Ali J, Pazzaglia P
J Clin Psychopharmacol . 1998 Apr; 18(2):154-65. PMID: 9555600
The study presented here compared the acute performance-impairing, subject-rated, and observer-rated effects of quazepam (15, 30, and 45 mg), triazolam (0.1875, 0.375, and 0.5625 mg), zolpidem (7.5, 15, and 22.5...
5.
Rush C, Kollins S, Pazzaglia P
Exp Clin Psychopharmacol . 1998 Apr; 6(1):32-44. PMID: 9526144
The discriminative-stimulus and participate-rated effects of a range of doses of d-amphetamine (2.5-20 mg), methylphenidate (5-40 mg), bupropion (50-400 mg), and triazolam (0.0625-0.5 mg) were tested in 5 humans trained...
6.
Rush C, Madakasira S, Hayes C, Johnson C, Goldman N, Pazzaglia P
Psychopharmacology (Berl) . 1997 May; 131(1):9-18. PMID: 9181630
The present study compared the acute subject-rated and performance-impairing effects of trazodone and triazolam in seven healthy humans. Trazodone (50, 100 and 200 mg), triazolam (0.125, 0.25, 0.50 mg) and...
7.
Marangell L, George M, Callahan A, Ketter T, Pazzaglia P, LHerrou T, et al.
Arch Gen Psychiatry . 1997 Mar; 54(3):214-22. PMID: 9075462
Background: Therapeutic effects of the tripeptide protirelin (thyrotropin-releasing hormone) have been postulated in the affective disorders, but direct assessment in humans has been hindered by poor blood-brain barrier permeability. Methods:...
8.
Marangell L, Ketter T, George M, Pazzaglia P, Callahan A, Parekh P, et al.
Am J Psychiatry . 1997 Feb; 154(2):224-30. PMID: 9016272
Objective: The author's goal was to investigate relationships between peripheral thyroid hormone levels and cerebral blood flow (CBF) and cerebral glucose metabolism in affectively ill patients. Method: Medication-free inpatients with...
9.
George M, Ketter T, Parekh P, Rosinsky N, Ring H, Pazzaglia P, et al.
J Neuropsychiatry Clin Neurosci . 1997 Jan; 9(1):55-63. PMID: 9017529
Functional neuroimaging studies have found abnormal anterior cingulate activity in depressed subjects, and other studies have shown that the cingulate gyrus becomes active in healthy subjects during interference tasks. The...
10.
Post R, Ketter T, Denicoff K, Pazzaglia P, Leverich G, Marangell L, et al.
Psychopharmacology (Berl) . 1996 Nov; 128(2):115-29. PMID: 8956373
With the increasing recognition of lithium's inadequacy as an acute and prophylactic treatment for many patients and subtypes of bipolar illness, the search for alternative agents has centered around the...